LB Pharmaceuticals Inc Common Stock
LBRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Operating Activities | – | – | – |
| Net Income | -$63,102 | -$6,275 | -$14,348 |
| Dep. & Amort. | $91 | $4 | $2 |
| Deferred Tax | $0 | $0 | $0 |
| Stock-Based Comp. | $3,161 | $295 | $431 |
| Change in WC | $3,313 | -$1,313 | $86 |
| Other Non-Cash | $3,485 | -$4,805 | $11,101 |
| Operating Cash Flow | -$53,052 | -$12,094 | -$2,728 |
| Investing Activities | – | – | – |
| PP&E Inv. | -$769 | -$25 | $0 |
| Net Acquisitions | $0 | $0 | $0 |
| Inv. Purchases | -$29,746 | -$33,985 | $0 |
| Inv. Sales/Matur. | $53,749 | $6,000 | $123 |
| Other Inv. Act. | $0 | $0 | $0 |
| Investing Cash Flow | $23,234 | -$28,010 | $123 |
| Financing Activities | – | – | – |
| Debt Repay. | $0 | $725 | $25,005 |
| Stock Issued | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 |
| Other Fin. Act. | $38,315 | $32,954 | -$2,043 |
| Financing Cash Flow | $38,315 | $33,679 | $22,962 |
| Forex Effect | $0 | $0 | $0 |
| Net Chg. in Cash | $8,497 | -$6,425 | $20,357 |
| Supplemental Information | – | – | – |
| Beg. Cash | $14,979 | $21,404 | $1,047 |
| End Cash | $23,476 | $14,979 | $21,404 |
| Free Cash Flow | -$53,821 | -$12,119 | -$2,728 |